Prognosis of Patients With Acute-on-chronic Liver Failure

Status Recruiting

Clinical Trial Summary

Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis. This study mainly prospectively analyze the clinical data of patients with chronic liver disease related acute liver failure admitted to the department of infectious diseases, Xiangya Hospital of Central South University, to analyze the prognosis of patients with chronic liver disease related acute on-chronic liver failure in Central South China. No additional interventions other than routine treatment will be added.

Clinical Trial Description

Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis and would help determine in whom the treatment is effective. This study mainly prospectively analyze the clinical data of patients with chronic liver disease related acute liver failure admitted to the department of infectious diseases, Xiangya Hospital of Central South University, to analyze the short-time and relatively long-term prognosis of patients with chronic liver disease related acute on-chronic liver failure. This is an observational study. All subjects will receive the currently recognized routine treatment of liver failure and corresponding etiological treatment if needed. The researchers will collect various clinical examination indexes of the subjects in the process of diagnosis and treatment, including but not limited to blood routine, biochemistry, coagulation function, liver imaging, therapeutic drugs, etc. Complications and prognosis of patients will be recorded. Blood samples, urine and stool samples of all subjects will be taken after enrollment and stored for probably testing in the future. This study has no additional intervention and treatment for subjects. All subjects will sign informed consent. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05393453
Study type	Observational
Source	Xiangya Hospital of Central South University
Contact	Yan Huang, Professor
Phone	13874854142
Email	drhyan@163.com
Status	Recruiting
Phase
Start date	June 1, 2022
Completion date	June 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05985863` - Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure	Phase 1/Phase 2
Not yet recruiting	`NCT04822922` - Safety of UC-MSC Transfusion for ACLF Patients	Phase 2
Recruiting	`NCT04578301` - Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Completed	`NCT04983108` - Utility of Liver and Splenic Stiffness in Predicting Esophageal Varices in Patients With Acute on Chronic Liver Failure
Withdrawn	`NCT05940610` - The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure	Phase 1/Phase 2
Not yet recruiting	`NCT05036031` - Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study
Recruiting	`NCT05019352` - Cytokine Adsorption in Acute-on-chronic Liver Failure	N/A
Recruiting	`NCT05421351` - Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF
Completed	`NCT02321371` - Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.	N/A
Not yet recruiting	`NCT06069037` - SALT for Treatment of Patients With Early ACLF	N/A
Completed	`NCT02965560` - Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver Failure
Recruiting	`NCT03713489` - Platelet Transfusion in HBV-related acute-on Chronic Liver Failure	N/A
Withdrawn	`NCT03629015` - Safety Study of Stemchymal® in Acute Liver Failure	Phase 1
Recruiting	`NCT04621812` - Role of Fecal Microbiota in Predicting Graft Rejection and Sepsis Among Recipients of Living Donor Liver Transplant in First Year.
Recruiting	`NCT04157465` - Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients	N/A
Suspended	`NCT03737448` - TRimetazidine for acUte on Chronic Liver Failure STudy	Phase 1
Recruiting	`NCT06128421` - Individual Nutrition Support in HBV-ACLF Patients at Nutrition Risk	N/A
Recruiting	`NCT05700708` - Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites
Completed	`NCT04238416` - Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF	Phase 1
Completed	`NCT03456518` - Pattern of Acute on Chronic Liver Failure in Patient With HCV Related Chronic Liver Disease

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.